LifeStance Health Group, Inc. (LFST)
USD 7.09
(-5.21%)
USD 7.09
(-5.21%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 280.28 Million USD | -35.96% |
| 2022 | 437.66 Million USD | 178.03% |
| 2021 | 157.41 Million USD | -56.58% |
| 2020 | 362.53 Million USD | 357.09% |
| 2019 | 79.31 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 279.87 Million USD | -0.15% |
| 2024 Q2 | 279.45 Million USD | -0.15% |
| 2023 Q2 | 454.3 Million USD | 5.0% |
| 2023 FY | 280.28 Million USD | -35.96% |
| 2023 Q1 | 432.66 Million USD | -1.14% |
| 2023 Q4 | 280.28 Million USD | -36.28% |
| 2023 Q3 | 439.88 Million USD | -3.17% |
| 2022 Q3 | 212.04 Million USD | 4.27% |
| 2022 FY | 437.66 Million USD | 178.03% |
| 2022 Q2 | 203.36 Million USD | 14.65% |
| 2022 Q1 | 177.38 Million USD | 12.68% |
| 2022 Q4 | 437.66 Million USD | 106.4% |
| 2021 Q1 | 387.29 Million USD | 6.83% |
| 2021 FY | 157.41 Million USD | -56.58% |
| 2021 Q4 | 157.41 Million USD | -0.02% |
| 2021 Q3 | 157.44 Million USD | 0.24% |
| 2021 Q2 | 157.06 Million USD | -59.45% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 362.53 Million USD | 0.0% |
| 2020 FY | 362.53 Million USD | 357.09% |
| 2019 FY | 79.31 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 79.123% |
| Addus HomeCare Corporation | 124.13 Million USD | -125.796% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -303.27% |
| Amedisys, Inc. | 346.76 Million USD | 19.171% |
| American Oncology Network, Inc. | 120.44 Million USD | -132.71% |
| Astrana Health, Inc. | 296.26 Million USD | 5.393% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 78.04% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -162.858% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -2919.67% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -10425.16% |
| COMPASS Pathways plc | 28.75 Million USD | -874.667% |
| DocGo Inc. | 15.16 Million USD | -1748.612% |
| The Ensign Group, Inc. | 1.78 Billion USD | 84.296% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -2394.749% |
| InnovAge Holding Corp. | 100.49 Million USD | -178.902% |
| Assure Holdings Corp. | 505 Thousand USD | -55401.98% |
| The Joint Corp. | 2 Million USD | -13914.25% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -73380.95% |
| ModivCare Inc. | 983.75 Million USD | 71.509% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -235475.186% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -15837.826% |
| Option Care Health, Inc. | 1.05 Billion USD | 73.474% |
| P3 Health Partners Inc. | 108.31 Million USD | -158.759% |
| P3 Health Partners Inc. | 108.31 Million USD | -158.759% |
| The Pennant Group, Inc. | 312.51 Million USD | 10.312% |
| Surgery Partners, Inc. | 2.03 Billion USD | 86.217% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -222.812% |
| The Oncology Institute, Inc. | 86.82 Million USD | -222.812% |